All News

TAMs may help predict response to PD-1 inhibitors in metastatic clear cell kidney cancer, Dr. Berkay Simsek reported at the 2025 Kidney Cancer Summit.

After my cancer diagnosis, I planned to go it alone but found unconditional acceptance from the cancer community once I took the first step.

An expert helps patients with metastatic breast cancer understand treatment sequencing, biomarker testing and emerging options to support decision-making.

The first patient in the U.S. has been dosed with a novel radioactive medicine to treat advanced breast cancer as part of an international clinical trial.

Dr. Jacob A. Sands shares how antibody-drug conjugates, such as Datroway, work to selectively target and destroy tumor cells among those with lung cancer.

After joining a creative survivors’ group, I discovered that emotional expression, art and connection offered a profound kind of healing beyond treatment.

Jake Messier uses TikTok to raise awareness about male breast cancer, calling out stigma and isolation that delay diagnosis and harm treatment outcomes.

Jake Messier uses TikTok to raise awareness about male breast cancer, advocate for inclusivity and foster community after his stage 4 diagnosis.

When treatment ended, people expected relief, but what I felt was loss, fear, and the weight of a life forever changed.

The FDA approved an investigational new drug application for ABT-301, clearing the way for a new clinical trial in metastatic colorectal cancer to begin.

After my diagnosis, I found a healing balm in an unexpected place. I never knew art would become so vital to my healing.

Dr. Olalekan O. Oluwole, discusses treating patients from underserved communities with CAR T-cell therapy, as well as highlighted the therapy's evolution.

Kasey Bowden highlights the importance of recognizing financial toxicity and shares advice with those who feel lost in the healthcare system during cancer.

CURE spoke with an expert to learn what patients need to know about immunotherapy-induced diabetes.

In July of 2025, the U.S. Food and Drug Administration approved various anti-cancer treatments and therapeutic approaches across a range of disease types.

LiveLung invites the Wilmington community to its monthly educational meeting.

The August LiveLung Virtual meeting will feature Nitin Ohri, MD, MS, Board Certified Radiation Oncologist and Professor of Radiation Oncology at Montefiore Einstein.

LiveLung invites the Triad lung cancer community to its monthly educational meeting.

CURE spoke with experts about radical cystectomy, or surgical removal of the bladder, for patients with bladder cancer.

Robotic and video-assisted thoracic surgery reduces recovery time for those with lung cancer, allowing some to leave the hospital the day after surgery.

BMT-CARE app boosted quality of life, lowered depression and PTSD symptoms, and improved coping mechanisms for caregivers of stem cell transplant patients.

Dr. Michael Wagner covers the basics of epithelioid hemangioendothelioma, a rare vascular cancer, spanning symptoms, diagnosis, treatment options and more.

CURE spoke with a thoracic surgeon about the impact of minimally invasive surgery for patients.

The U.S. FDA has granted fast track designation to treatment with CLD-201, an oncolytic virus, for patients with soft tissue sarcoma.

Dr. Jacob Sands discusses the significance of the FDA approval of Datroway for the treatment of patients with locally advanced or metastatic EGFR+ NSCLC.

SAR446523, an investigational antibody targeting GPRC5D, received FDA orphan drug status and is in phase 1 trials for relapsed/refractory multiple myeloma.

Dr. Janet Kukreja explains one urinary diversion option available to patients undergoing bladder removal.